BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21435988)

  • 1. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.
    Hompes D; Prevoo W; Ruers T
    Cancer Imaging; 2011 Mar; 11(1):23-30. PubMed ID: 21435988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
    He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
    Abdalla EK; Vauthey JN; Ellis LM; Ellis V; Pollock R; Broglio KR; Hess K; Curley SA
    Ann Surg; 2004 Jun; 239(6):818-25; discussion 825-7. PubMed ID: 15166961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?
    Mulier S; Ni Y; Jamart J; Michel L; Marchal G; Ruers T
    Ann Surg Oncol; 2008 Jan; 15(1):144-57. PubMed ID: 17906898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases.
    Ko S; Jo H; Yun S; Park E; Kim S; Seo HI
    World J Gastroenterol; 2014 Jan; 20(2):525-31. PubMed ID: 24574721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis.
    Bai H; Huangz X; Jing L; Zeng Q; Han L
    Hepatogastroenterology; 2015; 62(138):373-7. PubMed ID: 25916066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
    Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
    World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis.
    White RR; Avital I; Sofocleous CT; Brown KT; Brody LA; Covey A; Getrajdman GI; Jarnagin WR; Dematteo RP; Fong Y; Blumgart LH; D'Angelica M
    J Gastrointest Surg; 2007 Mar; 11(3):256-63. PubMed ID: 17458595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
    Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ
    Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of liver metastases from colorectal carcinoma.
    Feliberti EC; Wagman LD
    Cancer Control; 2006 Jan; 13(1):48-51. PubMed ID: 16508626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Baba H; Adam R
    Br J Surg; 2017 Apr; 104(5):570-579. PubMed ID: 28112813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis.
    van Amerongen MJ; Jenniskens SFM; van den Boezem PB; Fütterer JJ; de Wilt JHW
    HPB (Oxford); 2017 Sep; 19(9):749-756. PubMed ID: 28687147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
    Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
    Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
    Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
    Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.